Oral etoposide combined with oral arsenic plus retinoic acid for two cases with newly diagnosed high-risk acute promyelocytic leukemia during COVID19 pandemic

Oral etoposide combined with oral arsenic plus retinoic acid for two cases with newly diagnosed high-risk acute promyelocytic leukemia during COVID19 pandemic

Acute promyelocytic leukemia (APL) is a highly curable hematology malignancy. The major factor influence prognosis of APL is early deaths (ED) during the course of induction therapy, especially in high-risk APL. Therefore, effective reduction of white blood cells and correction of coagulation abnorm...

Full description

Bibliographic Details
Main Authors: Sheng-ye Lu, Li Wen-jing, Rui Lou, Rui Ma, Ji-hong Zhu, Hao Jiang, Prof., MD.
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Leukemia Research Reports
Subjects:
Acute promyelocytic leukemia
High-risk
Early deaths
Cytoreductive therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S221304892100025X

Internet

http://www.sciencedirect.com/science/article/pii/S221304892100025X

Similar Items